Investigation of Quinazoline Derivatives as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Dissertation, 2017
- Classification
-
Medizin, Gesundheit
- Keyword
-
Breast--Cancer
Quinazoline
Adenosine triphosphatase
Cell lines
- Event
-
Veröffentlichung
- (where)
-
Bonn
- (who)
-
Universitäts- und Landesbibliothek Bonn
- (when)
-
2018
- Creator
- URN
-
urn:nbn:de:hbz:5n-50017
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:40 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Krapf, Michael
- Universitäts- und Landesbibliothek Bonn
Time of origin
- 2018
Other Objects (12)
Investigation of carborane-based derivatives as inhibitors of the breast cancer resistance protein (ABCG2)
Investigation of Phthalazine, Quinazoline and Pyrimidine Derivatives as ABCG2 Inhibitors
Tetrahydroquinoline/4,5‐Dihydroisoxazole Molecular Hybrids as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2)
Structural and molecular characterization of lopinavir and ivermectin as breast cancer resistance protein (BCRP/ABCG2) inhibitors
New inhibitors for the ABCG2 transporter
Synthese und Untersuchung neuer ABCG2 Inhibitoren
New inhibitors for the ABCG2 transporter
Potent and selective ABCG2 inhibitors derived from tariquidar
2‐Carboranylquinazoline: The Path to an ABCG2 Inhibitor
Potent and selective ABCG2 inhibitors derived from tariquidar
Synthese, Testung und 3D-QSAR von ABCG2-Inhibitoren
Über ABCG2-Inhibitoren mit Heteroaryl-phenylamid- und Carborancarboxamid-Grundstruktur
Investigation of carborane-based derivatives as inhibitors of the breast cancer resistance protein (ABCG2)
Investigation of Phthalazine, Quinazoline and Pyrimidine Derivatives as ABCG2 Inhibitors
Tetrahydroquinoline/4,5‐Dihydroisoxazole Molecular Hybrids as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2)
Structural and molecular characterization of lopinavir and ivermectin as breast cancer resistance protein (BCRP/ABCG2) inhibitors
New inhibitors for the ABCG2 transporter
Synthese und Untersuchung neuer ABCG2 Inhibitoren
New inhibitors for the ABCG2 transporter
Potent and selective ABCG2 inhibitors derived from tariquidar
2‐Carboranylquinazoline: The Path to an ABCG2 Inhibitor
Potent and selective ABCG2 inhibitors derived from tariquidar
Synthese, Testung und 3D-QSAR von ABCG2-Inhibitoren
Über ABCG2-Inhibitoren mit Heteroaryl-phenylamid- und Carborancarboxamid-Grundstruktur
Investigation of carborane-based derivatives as inhibitors of the breast cancer resistance protein (ABCG2)
Investigation of Phthalazine, Quinazoline and Pyrimidine Derivatives as ABCG2 Inhibitors
Tetrahydroquinoline/4,5‐Dihydroisoxazole Molecular Hybrids as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2)
Structural and molecular characterization of lopinavir and ivermectin as breast cancer resistance protein (BCRP/ABCG2) inhibitors
New inhibitors for the ABCG2 transporter
Synthese und Untersuchung neuer ABCG2 Inhibitoren
New inhibitors for the ABCG2 transporter
Potent and selective ABCG2 inhibitors derived from tariquidar
2‐Carboranylquinazoline: The Path to an ABCG2 Inhibitor
Potent and selective ABCG2 inhibitors derived from tariquidar
Synthese, Testung und 3D-QSAR von ABCG2-Inhibitoren